MedPath

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

Not Applicable
Recruiting
Conditions
Lung Cancer
Gastrointestinal Cancer
Registration Number
NCT06420206
Lead Sponsor
M.D. Anderson Cancer Center
Brief Summary

To improve quality of life for participants with advanced cancer, support their families, and lower overall cost of care.

Detailed Description

Primary Objective:

To compare overall percentage of days spent in an acute care setting over the 30-day period from time of the index emergency department (ED), referred to as Acute Cancer Care Center (ACCC), visit for patients who receive the emergency department-based GOC intervention and those who do not.

Secondary Objective:

To obtain data on rates of admission to the ICU, death in the hospital setting, symptom improvement for participants hospitalized, hospice referral, survival, and 30-day care costs for participants who receive the GOC intervention in the ACCC and those who do not.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  1. Participant is at least 18 years old presenting to the triage area of the MDACC ACCC for treatment
  2. Participant has advanced lung or GI cancer. Advanced cancer patient defined as: locally recurrent or metastatic for which there is no curative treatment available.
  3. Participant screens positive for at least 2 of 3 triple threat conditions (dyspnea, altered mental status, or poor performance status)
  4. Participant has the ability to speak and write in English
  5. Participant has the ability to provide consent OR is accompanied by a LAR able to provide consent
Exclusion Criteria
  1. Participant is already enrolled in hospice
  2. Participant is comatose
  3. Participant has severe intellectual disability
  4. Participant has a history of dementia documented in the medical records
  5. Participant has baseline communication barriers such as aphasia or deafness
  6. Participant is new to MDACC, without established oncology care at our institution at time of ACCC arrival
  7. Participant is 18 years or older, currently cared for by pediatrics service
  8. Pregnant women
  9. Prisoners

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Quality Of Life Questionnairethrough study completion; an average of 1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MD Anderson Cancer Center

🇺🇸

Houston, Texas, United States

MD Anderson Cancer Center
🇺🇸Houston, Texas, United States
Ahmed Elsayem, MD,MPH
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.